The FDA has granted an accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received ≥2 prior anti–HER2-based regimens in the metastatic setting.
Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard
The American Cancer Society’s report shows a mix of lower death rates and rising cancer incidence rates for some groups, especially younger women.
Each of the city’s opera houses is presenting a different production of the Mozart classic. With arts cuts looming, it looks like a last hurrah.
There is nothing quite like opening night of Teatro alla Scala in Milan, a temple of opera, for pomp, pageantry and politics.
As organizations become more global, matrixed, and complex, they are requiring employees to collaborate with more internal colleagues and external contacts than ever before. According…
The number of male registered nurses in the U.S. has nearly tripled since the early 2000s
Googling Is for Old People. That’s a Problem for Google.
A century after his death, the composer of “La Bohème,” “Tosca” and “Madama Butterfly” still dominates the repertoire like no one since.
Nature Biotechnology – The Nobel Prize in medicine was awarded for the discovery of miRNA, but miRNA therapeutics have a long way to go before…
Should you use your gut feel or not? Recent research suggests that it can be useful, especially in highly uncertain circumstances where further data gathering…
